Key Takeaways Quest Diagnostics will co-develop a blood test with MD Anderson to detect elevated cancer risk. DGX will refine and validate MD Anderson's MCaST model for its lab-developed cancer risk test. DGX shares rose 2.6% after the news, adding to a 31.3% gain over the past year.Quest Diagnostics Inc. (DGX) recently announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson). The partnership will focus on improving the assessment of elevated risk of cancer in individ ...

SECAUCUS, N.J., June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to improve the assessment of elevated risk of cancer in individuals who would benefit from medically appropriate cancer screenings. Under terms of the agreement, Quest will develop and validate a laboratory-developed blood test based on circulating protein biomarkers as ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops data centers, is pleased to announce the release of the following report to shareholders by Michel Amar, Chairman and Chief Executive Office ...

Quest Diagnostics (DGX) FY Conference June 03, 2025 11:00 AM ET Speaker0 Thanks again for joining us at this year's William Blair Growth Stock Conference. This morning, we're very pleased to have the team from Quest Diagnostics joining us here. We have the CEO, Jim Davis from Investor Relations, Sean Bevek here in the front row. Format for today will be a thirty minute presentation in this room, then we'll go to the breakout afterwards, which is an ad in the Adler Room on the Second Floor. And then for comp ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, June 02, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide unaudited comparative Bitcoin (“BTC”) production results for the month ended May 31, 2025, ...

Core Viewpoint - Digi Power X Inc. has announced an at-the-market sales agreement to raise up to US$100 million through the issuance of subordinate voting shares, aimed at supporting its strategic initiatives and operations [2][3][4]. Group 1: At-the-Market Offering - The ATM Agreement allows Digi Power X to issue subordinate voting shares with an aggregate offering price of up to US$100 million [3]. - A cash commission of up to 3.0% will be paid to the Agent for the services related to the ATM Equity Program [3]. - The proceeds from the ATM Equity Program will primarily be used for general corporate purposes, including funding ongoing operations, completing data center construction, repaying debt, and potential acquisitions [3][4]. Group 2: Company Position and Strategy - The CEO of Digi Power X stated that the company is in a strong position, being debt-free with solid cash reserves, and is focused on scaling its AI-ready Modular Solution platform [4]. - The company has not yet distributed any subordinate voting shares under the ATM Agreement [4]. Group 3: Regulatory and Compliance Information - The offer and sale of shares will be conducted under a prospectus supplement dated May 30, 2025, and a base shelf prospectus dated May 15, 2025, which have been filed with regulatory authorities [6]. - The ATM Equity Program will not involve sales on the TSX Venture Exchange or any other Canadian trading market [5].

With women’s health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women’s health diagnostics market to expand at a compound annual rate of 9.25% through 2030, driven by technological advancements, increasing healthcare expenditures, and initiatives for early detection of women-specific conditions like reproductive health issues, breast cancer, osteoporosis and more. Two U.S. healthcare ...

Core Viewpoint - Digi Power X Inc. has announced a collaboration with Super Micro Computer, Inc. to deploy customized GPU rack solutions at its new data center in Alabama, marking a significant step in expanding its AI and high-performance computing infrastructure [1][2]. Group 1: Collaboration Details - The collaboration will initiate with an initial deployment aimed at operational readiness within 120 days, with full test operations expected in Q4 2025 [2]. - The project is set to lay the groundwork for broader expansion at the Alabama site, with plans to scale up to 22 megawatts (MW) in 2026 and 55 MW by 2027 [2]. Group 2: Company Overview - Digi Power X is described as a vertically integrated power infrastructure company focused on developing advanced data centers for high-performance computing [1]. - The company aims to drive the expansion of sustainable energy assets through its innovative energy infrastructure [3].

Core Viewpoint - Quest Diagnostics (DGX) has experienced a significant share price increase of 25.6% over the past year, outperforming both the industry and the S&P 500 [1] Company Overview - Quest Diagnostics, based in Secaucus, NJ, provides a wide range of diagnostic information services to patients, clinicians, and healthcare organizations, serving approximately half of U.S. hospitals [2] - The company’s growth strategy includes strategic acquisitions and continuous quality improvement [2] Growth Factors - The share price rally is attributed to strong momentum in advanced diagnostics, particularly in areas such as advanced cardiometabolic, autoimmune, brain health, oncology, and women's and reproductive health, all showing double-digit growth in Q1 2025 [3] - Demand for AD-detect blood tests for Alzheimer's disease risk is notably high, with advanced cardiometabolic and autoimmune testing expected to maintain strong growth throughout the year [3] Acquisitions and Strategic Initiatives - In 2024, Quest Diagnostics completed eight acquisitions, including LifeLabs and PathAI Diagnostics, enhancing its market presence and AI adoption for improved diagnostics [4] - The company’s Hospital channel is addressing market challenges faced by hospitals, and enhancements to the QuestHealth.com platform have led to increased first-time orders and the introduction of 10 new tests [5] Operational Improvements - The use of automation and AI is central to Quest Diagnostics' strategy for operational improvements, targeting 3% annual cost savings and productivity enhancements through the Invigorate program [6] - A collaboration with Google Cloud aims to streamline data management and utilize GenAI for personalized experiences [6] Financial Estimates - The Zacks Consensus Estimate projects an 8.6% increase in earnings per share (EPS) for 2025 to $9.70, with revenues expected to grow by 9.2% to $10.78 billion [10]

Core Insights - The survey indicates that a significant portion of Americans are eager to take an active role in their healthcare, with 92% preparing for future health needs, yet many face barriers to accessing care and feel their doctors do not prioritize preventive discussions [1][9][11] Group 1: Health Awareness and Engagement - 40% of Americans know their streaming passwords by heart, while only 19% are aware of their cholesterol levels, highlighting a gap in health awareness [3] - Family medical history is often overlooked, with 56% of Gen Z knowing their streaming passwords compared to only 31% knowing their family medical history [4] - Social media influences health habits, with 24% of Americans seeking health advice from influencers and 33% taking medical action after seeing personal health stories online [5] Group 2: Health Priorities and Habits - 70% of Americans rate their health as good or excellent, but 30% describe it as fair or poor, citing stress, poor sleep, and lack of exercise as major contributors [6][9] - Sleep is prioritized by 71% of Americans, followed by hydration (65%) and exercise (62%), with over half also prioritizing vitamins, diet, and annual physicals [7] Group 3: Preventive Care and Future Planning - About 51% of Americans focus on regular checkups and screenings, while 49% rely on healthcare professionals for health risk identification [10] - 92% of Americans are actively preparing for their future health, with 60% trying to stay active and 57% maintaining a healthy diet [9] Group 4: Barriers to Healthcare Access - 37% of Americans report experiencing barriers to medical care, with younger generations facing more significant challenges [11] - 63% of Americans are unaware that they can purchase lab tests without a doctor's visit, indicating a need for increased awareness of alternative healthcare access [12] Group 5: Quest Diagnostics' Role - Quest Diagnostics offers consumer-initiated lab testing, allowing individuals to access tests without prior doctor visits, with physician oversight available for result discussions [13][14] - The company aims to empower individuals with affordable, high-quality healthcare, providing insights that can guide health management [16][17]